Listen to this article

Dr. Neel Belani is the newly appointed Clinical Investigator at START New Jersey, part of The START Center for Cancer Research’s global network of community-based clinical trial sites specializing in early-phase oncology trials. Dr. Belani joins START through its collaboration with Astera Cancer Care, a leading oncology practice and partner within the OneOncology network.

“I’m excited to join START and be part of a network that is redefining how early-phase oncology research is delivered,” said Dr. Belani. “Expanding access to clinical trials in the community setting is critical to ensuring more patients have the opportunity to benefit from innovative therapies, and I look forward to helping advance that mission.”

Dr. Belani is a board-certified medical oncologist with a strong focus on thoracic oncology and early-phase clinical research. Prior to joining START, he was an attending oncologist and clinical investigator, serving as a Principal Investigator on multiple clinical trials and a Sub-Investigator on more than 200 Phase 1 studies.

Dr. Belani will conduct leading clinical trials and expand access to early-phase oncology studies for patients across New Jersey.

Social: www.linkedin.com/in/neel-belani-md-60122113/

Education: Dr. Belani earned his MD from Rutgers New Jersey Medical School, and his MBA from Rutgers Business School.

Announce your new employees, promotions, board positions, community notes and leaders in your organization to NJBIZ’s influential audience. The information in the Movers & Shakers section is provided by the submitter.

Click here to make a Movers & Shakers submission and to find out more.